<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05121935</url>
  </required_header>
  <id_info>
    <org_study_id>200340</org_study_id>
    <nct_id>NCT05121935</nct_id>
  </id_info>
  <brief_title>MAL-ED Metabolic: A Follow-Up of Chronic Disease at Puberty</brief_title>
  <official_title>MAL-ED Metabolic: A Follow-Up of Chronic Disease at Puberty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Haydom Lutheran Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The concept that the roots of cardiometabolic disease start in early life was established by&#xD;
      Dr. David Barker, who documented relationships between low birthweight (as a marker for&#xD;
      challenges during gestation) and later cardiovascular disease (CVD). Later work has suggested&#xD;
      that post-natal challenges (similar to prenatal ones) may also exhibit links to later&#xD;
      cardiometabolic disease, with the strongest links appearing to be between low weight in early&#xD;
      childhood and later hypertension and high waist circumference (WC). However, assessments for&#xD;
      the relationship between early childhood challenges and insulin resistance and glucose&#xD;
      regulation have been lacking and long-term cohort studies are few. In this project, we aim to&#xD;
      assess children initially followed as part of The Etiology, Risk Factors, and Interactions of&#xD;
      Enteric Infections and Malnutrition and the Consequences for Child Health (MAL-ED) study,&#xD;
      where they received frequent measures of anthropometry and laboratory assessments for&#xD;
      intestinal pathogens. These children are now of peri-pubertal age--a time period associated&#xD;
      with metabolic shifts. We will assess for glucose dysregulation and findings associated with&#xD;
      the metabolic syndrome, and we will analyze potential associations between current chronic&#xD;
      disease risk findings with early life poor growth and intestinal pathogen carriage rate. As&#xD;
      such, we hope to uncover potential targets in early life health to reduce later chronic&#xD;
      disease risk.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The relationship between prenatal challenges and later risk for chronic disease has been well&#xD;
      established. Our group previously assessed the hypothesis that post-natal challenges (similar&#xD;
      to prenatal ones) would exhibit links to later cardiometabolic disease. This was performed&#xD;
      using retrospective data from a long-term cohort of children in Guatemala, demonstrating&#xD;
      novel findings that higher degrees of diarrhea burden in the first 6 months of life (as a&#xD;
      marker of nutritional and/or inflammatory stressors) were associated with a greater risk of&#xD;
      metabolic syndrome as adults The causes of these findings are not known, though postulated&#xD;
      mechanisms include epigenetic reprograming of metabolic rate, hormonal regulation and&#xD;
      vascular tone. Unfortunately, long-term cohort studies are few, limiting opportunities to&#xD;
      evaluate these links prospectively.&#xD;
&#xD;
      The Haydom Global Health Research Center in north central Tanzania represents an important&#xD;
      rural setting for performing high-quality medical research in sub-Saharan Africa (5). The&#xD;
      region around Haydom has a high degree of stunting and enteric pathogen carriage among a&#xD;
      cohort of children followed in the area from 2009-2013 as part of the multi-country study&#xD;
      &quot;The Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the&#xD;
      Consequences for Child Health (MAL-ED).&quot;&#xD;
&#xD;
      These children followed in Haydom during MAL-ED had monthly anthropometry and stool pathogen&#xD;
      analysis, as well as extensive demographic data. This provides an opportunity to follow up on&#xD;
      these children to assess for potential links between early life challenges (both enteric&#xD;
      disease, infections and nutritional deficiencies) and later chronic disease risk, including&#xD;
      lipid abnormalities, glucose intolerance and blood pressure elevations. The current proposal&#xD;
      is to follow up on these children at the age of typical entry into puberty, as this is a&#xD;
      common shift in metabolism when many children begin to exhibit metabolic abnormalities. We&#xD;
      will assess these children for multiple measures:&#xD;
&#xD;
        -  Anthropometry (height, weight, BMI, waist circumference)&#xD;
&#xD;
        -  Assessment of pubertal stage by exam or questionnaire&#xD;
&#xD;
        -  Blood pressure&#xD;
&#xD;
        -  Lipids (LDL, HDL, triglycerides)&#xD;
&#xD;
        -  CRP&#xD;
&#xD;
        -  Oral glucose tolerance test (OGTT)&#xD;
&#xD;
        -  Fasting insulin&#xD;
&#xD;
        -  Metabolic syndrome (MetS) severity score&#xD;
&#xD;
        -  Blood saved for future epigenetic testing&#xD;
&#xD;
      We will use linear and and logistic regression to determine associations between 1) mean&#xD;
      number of monthly pathogens (individual pathogens and in aggregate) and 2) reported symptoms&#xD;
      (fever, cough, diarrhea), with multiple MetS-related outcomes: BMI percentile, WC, fasting&#xD;
      insulin, 2-hour glucose following OGTT, triglycerides, HDL cholesterol, normalized BP and a&#xD;
      MetS diagnosis.&#xD;
&#xD;
      The underlying hypothesis is that there will be consistent links between features of MetS (in&#xD;
      particular blood pressure, waist circumference and insulin resistance) with 1) enteric&#xD;
      pathogen burden (overall and for particularly virulent pathogens such as Enterotoxigenic&#xD;
      E.coli) and 2) poor early life growth.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2022</start_date>
  <completion_date type="Anticipated">February 1, 2031</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Current Systolic BP--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current systolic BP z-score vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Current Systolic BP--relationship to BMI z-score at age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current systolic BP z-score vs. BMI z-score at age 2 years (from MAL-ED), adjusted for current BMI z-score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current Diastolic BP--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current diastolic BP z-score vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current Diastolic BP--relationship to BMI z-score at age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current diastolic BP z-score vs. BMI z-score at age 2 years (from MAL-ED), adjusted for current BMI z-score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current BMI z-score--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current BMI z-score vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current waist circumference--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current waist circumference vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic syndrome (MetS) severity score--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current MetS severity z-score vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current metabolic syndrome (MetS) severity score--relationship to BMI z-score at age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current MetS severity z-score vs. number enteric pathogens by age 2 years (from MAL-ED), adjusted by current waist circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current glucose from oral glucose tolerance test (OGTT) at 2 hours--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current 2-hour OGTT glucose vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current glucose from oral glucose tolerance test (OGTT) at 2 hours--relationship to BMI z-score at age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current 2-hour OGTT glucose vs. BMI z-score at age 2 years (from MAL-ED), adjusted by current BMI z-score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current fasting triglycerides--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current ln(triglycerides) vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current fasting triglycerides--relationship to BMI z-score at age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current ln(triglycerides) vs. BMI z-score at age 2 years (from MAL-ED), adjusted by current BMI z-score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current HDL cholesterol--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current HDL cholesterol vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current HDL cholesterol--relationship to BMI z-score at age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current HDL cholesterol vs. BMI z-score at age 2 years (from MAL-ED), adjusted by current BMI z-score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current fasting glucose--relationship to number of enteric pathogens by age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current fasting glucose vs. number enteric pathogens by age 2 years (from MAL-ED)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current fasting glucose--relationship to BMI z-score at age 2 years</measure>
    <time_frame>Measured during current study (1 year +/- 3 months)</time_frame>
    <description>Regression analysis of current fasting glucose vs. BMI z-score at age 2 years (from MAL-ED), adjusted by current BMI z-score</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">254</enrollment>
  <condition>Growth Failure</condition>
  <condition>Intestinal Infection</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>MAL-ED cohort</arm_group_label>
    <description>Children initially followed from birth through 2 years old in the MAL-ED study (with some additional assessments in follow-up studies since then).</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      We will collect serum for later testing of markers of health, nutrition and inflammation,&#xD;
      including C-reactive protein, IGF-1 and insulin.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This is a follow-up study of children who were originally in the MAL-ED cohort.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participated in original MAL-ED cohort&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Did not participate in original MAL-ED cohort&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Mark D DeBoer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Estomih Mduma, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Haydom Global Health Research Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark D DeBoer, MD</last_name>
    <phone>14349245956</phone>
    <email>deboer@virginia.edu</email>
  </overall_contact>
  <reference>
    <citation>DeBoer MD, Lima AA, Or√≠a RB, Scharf RJ, Moore SR, Luna MA, Guerrant RL. Early childhood growth failure and the developmental origins of adult disease: do enteric infections and malnutrition increase risk for the metabolic syndrome? Nutr Rev. 2012 Nov;70(11):642-53. doi: 10.1111/j.1753-4887.2012.00543.x. Review.</citation>
    <PMID>23110643</PMID>
  </reference>
  <reference>
    <citation>DeBoer MD, Chen D, Burt DR, Ramirez-Zea M, Guerrant RL, Stein AD, Martorell R, Luna MA. Early childhood diarrhea and cardiometabolic risk factors in adulthood: the Institute of Nutrition of Central America and Panama Nutritional Supplementation Longitudinal Study. Ann Epidemiol. 2013 Jun;23(6):314-20. doi: 10.1016/j.annepidem.2013.03.012. Epub 2013 Apr 19.</citation>
    <PMID>23608305</PMID>
  </reference>
  <reference>
    <citation>Mduma ER, Gratz J, Patil C, Matson K, Dakay M, Liu S, Pascal J, McQuillin L, Mighay E, Hinken E, Ernst A, Amour C, Mvungi R, Bayyo E, Zakaria Y, Kivuyo S, Houpt ER, Svensen E. The etiology, risk factors, and interactions of enteric infections and malnutrition and the consequences for child health and development study (MAL-ED): description of the Tanzanian site. Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S325-30. doi: 10.1093/cid/ciu439.</citation>
    <PMID>25305305</PMID>
  </reference>
  <reference>
    <citation>Scharf RJ, Rogawski ET, Murray-Kolb LE, Maphula A, Svensen E, Tofail F, Rasheed M, Abreu C, Vasquez AO, Shrestha R, Pendergast L, Mduma E, Koshy B, Conaway MR, Platts-Mills JA, Guerrant RL, DeBoer MD. Early childhood growth and cognitive outcomes: Findings from the MAL-ED study. Matern Child Nutr. 2018 Jul;14(3):e12584. doi: 10.1111/mcn.12584. Epub 2018 Feb 2.</citation>
    <PMID>29392824</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 3, 2021</study_first_submitted>
  <study_first_submitted_qc>November 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Mark D. DeBoer, MD, MSc., MCR</investigator_full_name>
    <investigator_title>Professor of Pediatrics, Division of Pediatric Endocrinology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Failure to Thrive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

